Gastrointestinal Infections News

In this video, C. Jonathan D. Foster, DO, FACOI, discusses results from the PRISM3 trial assessing CP101, an investigational microbiome therapeutic, for recurrent Clostridioides difficile infection.

In this video, C. Jonathan D. Foster, DO, FACOI, discussed a study on the use of vonoprazan-based regimens for the treatment of Helicobacter pylori infection presented at the ACG Annual Scientific Meeting.

C. Jonathan D. Foster, DO, FACOI, spoke with Healio about the utility of repeat Helicobacter pylori biopsies in patients with previously negative tests.

During the 2021 match cycle, a presence on Twitter and having specialized training tracks were associated with a higher likelihood of filling infectious disease fellowships programs, researchers found.

HIV captured me during my first clinical rotation in medical school, early in the Plague Years, around the same time that AIDS was getting its name from CDC.

Consultations, testing and treatment of hepatitis B and C virus fell significantly during the first year of the COVID-19 pandemic, with many centers seeing declines of more than 75% in all categories, according to a presentation.

In this video, Paul Feuerstadt, MD, FACG, AGAF, spoke about new changes to the American College of Gastroenterology’s guidelines on Clostridioides difficile infection treatment, which were discussed at the ACG Annual Scientific Meeting.

In this video, Paul Feuerstadt, MD, FACG, AGAF, discussed the annual incidence rate of Clostridioides difficile infection during and in the years preceding the COVID-19 pandemic.

WASHINGTON – In this video, infectious disease pharmacist Kerry LaPlante, PharmD, FCCP, FIDSA, discusses a presentation she gave at the World Anti-Microbial Resistance Congress on Clostridioides difficile infection.

November is Clostridioides Difficile Awareness Month in the United States, as declared by the C Diff Foundation, a nonprofit patient advocacy group.